WWolfe Research TTesla · TSLA

Wolfe Research Keeps Tesla’s ‘Peerperform’ Rating

Jul 31, 2025· 1 min read· Reproduced verbatim
Rating
Hold
Price target
Previous
Implied upside

Wolfe Research analyst Emmanuel Rosner reiterated a Peerperform rating on Tesla.

“TSLA shares are down 21% YTD, below the broader S&P up 8% and RIVN down 2%, with Ford up 9% and GM down 2%.

Near-term, Street estimates still appear high, especially for 2025 and 2026.

And FCF is likely to remain under pressure, with strong growth in the company’s burgeoning Energy business a key swing factor.

That said, this name trades more around the narrative than the numbers. And net-net, we tactically see an improving narrative from here.

Tesla has several catalysts coming w/r/t FSD and robotaxi, including an expansion of their AV service into several new US markets (San Francisco, Nevada, Arizona, Florida, etc).

The company plans to unlock hands-free / eyes-off autonomy for FSD owners in select US locations by YE25.

Supervised FSD in China and Europe is expected to launch over the next ~12 months. And Optimus is expected to enter scale production in 2026.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.